XENOBIOTIC AND ENDOBIOTIC INHIBITORS OF CYTOCHROME-P-450DBL FUNCTION, THE TARGET OF THE DEBRISOQUINE SPARTEINE TYPE POLYMORPHISM

被引：114

作者：

FONNEPFISTER, R

MEYER, UA

机构：

来源：

BIOCHEMICAL PHARMACOLOGY | 1988年 / 37卷 / 20期

关键词：

D O I：

10.1016/0006-2952(88)90063-9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：3829 / 3835

页数：7

共 38 条

[11] A HUMAN CYTOCHROME-P-450 CHARACTERIZED BY INHIBITION STUDIES AS THE SPARTEINE DEBRISOQUINE MONOOXYGENASE [J].

INABA, T ;

NAKANO, M ;

OTTON, SV ;

MAHON, WA ;

KALOW, W .

CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1984, 62 (07) :860-862

[12]

INABA T, 1985, DRUG METAB DISPOS, V13, P443

[13]

KRONBACH T, 1987, ANAL BIOCH, V162, P2432

[14] CHRONIC PARKINSONISM IN HUMANS DUE TO A PRODUCT OF MEPERIDINE-ANALOG SYNTHESIS [J].

LANGSTON, JW ;

BALLARD, P ;

TETRUD, JW ;

IRWIN, I .

SCIENCE, 1983, 219 (4587) :979-980

[15] PARGYLINE PREVENTS MPTP-INDUCED PARKINSONISM IN PRIMATES [J].

LANGSTON, JW ;

IRWIN, I ;

LANGSTON, EB ;

FORNO, LS .

SCIENCE, 1984, 225 (4669) :1480-1482

[16] SINGLE-DOSE QUINIDINE TREATMENT INHIBITS METOPROLOL OXIDATION IN EXTENSIVE METABOLIZERS [J].

LEEMANN, T ;

DAYER, P ;

MEYER, UA .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 29 (06) :739-741

[17] INTERACTION OF CHLORPROMAZINE AND NORTRIPTYLINE IN PATIENTS WITH SCHIZOPHRENIA [J].

LOGA, S ;

CURRY, S ;

LADER, M .

CLINICAL PHARMACOKINETICS, 1981, 6 (06) :454-462

[18]

MEIER PJ, 1983, GASTROENTEROLOGY, V85, P682

[19] THE MOLECULAR MECHANISMS OF 2 COMMON POLYMORPHISMS OF DRUG OXIDATION - EVIDENCE FOR FUNCTIONAL-CHANGES IN CYTOCHROME-P-450 ISOZYMES CATALYZING BUFURALOL AND MEPHENYTOIN OXIDATION [J].

MEYER, UA ;

GUT, J ;

KRONBACH, T ;

SKODA, C ;

MEIER, UT ;

CATIN, T ;

DAYER, P .

XENOBIOTICA, 1986, 16 (05) :449-464

[20]

MEYER UA, 1988, MICROSOMES DRUG OXID, P209

← 1 2 3 4 →